Usefulness of Baseline Plasma Myeloperoxidase Levels as an Independent Predictor of Myocardial Infarction at Two Years in Patients Presenting With Acute Coronary Syndrome
- 15 May 2007
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 99 (10) , 1364-1368
- https://doi.org/10.1016/j.amjcard.2006.12.060
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Usefulness of the White Blood Cell Count as a Predictor of Angiographic Findings in an Unselected Population Referred for Coronary AngiographyThe American Journal of Cardiology, 2006
- Usefulness of Anemia in Men as an Independent Predictor of Two-Year Cardiovascular Outcome in Patients Presenting With Acute Coronary SyndromeThe American Journal of Cardiology, 2006
- Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart FailureCirculation, 2005
- Prognostic Value of Myeloperoxidase in Patients with Chest PainNew England Journal of Medicine, 2003
- Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary SyndromesCirculation, 2003
- C-reactive protein and other inflammatory risk markers in acute coronary syndromesPublished by Elsevier ,2003
- ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary articleJournal of the American College of Cardiology, 2002
- Inflammation and Long-Term Mortality After Non–ST Elevation Acute Coronary Syndrome Treated With a Very Early Invasive Strategy in 1042 Consecutive PatientsCirculation, 2002
- Association Between Myeloperoxidase Levels and Risk of Coronary Artery DiseaseJAMA, 2001
- Cytomegalovirus Infection With Interleukin-6 Response Predicts Cardiac Mortality in Patients With Coronary Artery DiseaseCirculation, 2001